Christopher Thomas Scott

Baylor University - Center for Medical Ethics and Health Policy

Dalton Tomlin Chair in Health Policy, Professor of Medicine, Medical Ethics, and Health Policy, Associate Director of Health Policy

1 Baylor Plaza, Suite 310D

Houston, TX 77030

United States

SCHOLARLY PAPERS

6

DOWNLOADS

399

SSRN CITATIONS

3

CROSSREF CITATIONS

2

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

The Pick-and-Shovel Play: Bioethics for Gene-Editing Vector Patents

North Carolina Law Review, 2019, vol. 97, pp. 1497–1552
Number of pages: 56 Posted: 28 Nov 2018 Last Revised: 28 Jul 2019
Jacob S. Sherkow and Christopher Thomas Scott
New York Law School and Baylor University - Center for Medical Ethics and Health Policy
Downloads 114 (244,037)

Abstract:

Loading...

Patent, Gene-Editing, IP, CRISPR, ZFN, TALEN, Vector, Cell, Secret, Pick-and-Shovel, Arbitrage, Equipment, Ethics, Bioethics, Gene Therapy, Risk, Preclinical, Informed Consent, Drug Cost, Drug Price, Price, Cost, Disclosure, Consumer, Standards, SEPs, SSO

2.

Myriad Stands Alone

Nature Biotechnology, Vol. 32, p. 620, 2014, NYLS Legal Studies Research Paper No. 13/14 #83
Number of pages: 1 Posted: 26 Aug 2014
Jacob S. Sherkow and Christopher Thomas Scott
New York Law School and Baylor University - Center for Medical Ethics and Health Policy
Downloads 92 (282,247)
Citation 1

Abstract:

Loading...

myriad, gene, genetics, patent, intellectual property, biotechnology, supreme court

3.

Stem Cell Patents after the America Invents Act

Cell Stem Cell, Vol. 16, pp. 461-464, 2015
Number of pages: 4 Posted: 15 May 2015
Jacob S. Sherkow and Christopher Thomas Scott
New York Law School and Baylor University - Center for Medical Ethics and Health Policy
Downloads 71 (329,591)

Abstract:

Loading...

patents, intellectual property, ip, AIA, PTO, cell, stem cell, bioscience, biotechnology, law, biogatekeeper, consumer watchdog, scotus, supreme court

4.

Unsettled Expectations: How Recent Patent Decisions Affect Biotech

Nature Biotechnology, Vol. 29, No. 3, pp. 229-230, March 2011, Thomas Jefferson School of Law Research Paper No. 1792985
Number of pages: 2 Posted: 27 Mar 2011 Last Revised: 19 May 2016
Brenda M. Simon and Christopher Thomas Scott
University of California, San Diego (UCSD) and Baylor University - Center for Medical Ethics and Health Policy
Downloads 44 (412,836)

Abstract:

Loading...

patent, biotechnology, validity, obviousness, eligibility, Bilski, myriad, stem cells

5.

Pluripotent Patents Make Prime Time: An Analysis of the Emerging Landscape

Nature Biotechnology, Vol. 28, No. 6, pp. 557-559, June 2010 , Thomas Jefferson School of Law Research Paper No. 1622556
Number of pages: 3 Posted: 15 Jul 2010 Last Revised: 19 May 2016
Brenda M. Simon, Charles E. Murdoch and Christopher Thomas Scott
University of California, San Diego (UCSD), University of Alberta and Baylor University - Center for Medical Ethics and Health Policy
Downloads 41 (424,083)

Abstract:

Loading...

Patents, pluripotency, stem cells

6.

The Rise of the Ethical License

35 Nature Biotechnology 22 (2017)
Number of pages: 3 Posted: 13 Jan 2017 Last Revised: 16 Aug 2017
Christi J. Guerrini, Margaret Curnutte, Jacob S. Sherkow and Christopher Thomas Scott
Baylor College of Medicine, Baylor College of Medicine, New York Law School and Baylor University - Center for Medical Ethics and Health Policy
Downloads 37 (440,367)

Abstract:

Loading...

patent, license, CRISPR, gene drives, NIPT, ethics, Broad Institute, Monsanto